0001171843-23-004119.txt : 20230626
0001171843-23-004119.hdr.sgml : 20230626
20230626165400
ACCESSION NUMBER: 0001171843-23-004119
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230619
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nunes Anne
CENTRAL INDEX KEY: 0001982862
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 231042985
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
3
1
ownership.xml
X0206
3
2023-06-19
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001982862
Nunes Anne
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
SVP, Chief Operations Officer
Common Stock
3293
D
Restricted Stock Unit
0
Common Stock
4982
D
Stock Option (Right to Buy)
43.27
2031-10-01
Common Stock
8640
D
Stock Option (Right to Buy)
47.60
2031-10-01
Common Stock
9225
D
Restricted Stock Unit
0
Common Stock
5122
D
Stock Option (Right to Buy)
28.14
2032-03-11
Common Stock
8763
D
Restricted Stock Unit
0
Common Stock
9886
D
Stock Option (Right to Buy)
29.60
2033-03-09
Common Stock
10629
D
Each RSU represents the contingent right to receive one share of the Company's common stock. 7,473 RSUs were granted on October 1, 2021 and the RSUs vest in three equal annual installments beginning October 1, 2022.
The stock options vest in three equal annual installments beginning on October 1, 2022.
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
Each RSU represents the contingent right to receive one share of the Company's common stock. 7,683 RSUs were granted on March 11, 2022 and the RSUs vest in three equal annual installments beginning March 11, 2023.
The stock options vest in three equal annual installments beginning on March 11, 2023.
Each RSU represents the contingent right to receive one share of the Company's common stock. 9,886 RSUs were granted on March 9, 2023 and the RSUs vest in three equal annual installments beginning March 9, 2024.
The stock options vest in three equal annual installments beginning on March 9, 2024.
/s/ Anne Nunes
2023-06-26